₹4.33 Crores | Listing at BSE | Wed, Feb 4, 2026 - Fri, Feb 27, 2026
Dr Lalchandani Labs Ltd Rights Issue comprises 0.4332 Cr equity shares aggregating to ₹4.33 Cr, offered at an issue price of ₹10 per share with a face value of ₹10 per share.
The record date for determining eligible shareholder is Jan 27, 2026, with the Rights Issue being offered in the entitlement ratio of 1 : 1.
The term of payment is defined as following : The entire Issue Price of Rs.10/- per share is payable on Application.
The Rights Entitlements are expected to be credited to eligible demat accounts on Feb 23, 2026.
The Rights Issue opens on Feb 4, 2026, and closes on Feb 27, 2026, with renunciation of Rights Entitlements permitted up to Feb 24, 2026.
The deemed date of allotment is Feb 23, 2026, following which the equity shares are expected to be credited to demat accounts on Feb 24, 2026 and listed at the BSE on Feb 25, 2026.
Cameo Corporate Services Ltd. is the Registrar to the Issue.
Investors are advised to refer to the Dr Lalchandani Labs Ltd Letter of Offer for detailed information, including risk factors, issue terms, and procedural details.
Record Date
Tue, Jan 27, 2026
Entitlement Ratio
1 : 1
Open Date
Wed, Feb 4, 2026
Close Date
Fri, Feb 27, 2026
The entire Issue Price of Rs.10/- per share is payable on Application.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|
| Total Income | 4.46 | 5.05 |
| Profit After Tax | 0.40 | 0.62 |
| NET Worth | 9.96 | 9.54 |
| Reserves and Surplus | 5.62 | 5.21 |
| Amount in ₹ Crore | ||
Dr Lalchandani Labs Limited is a New Delhi-based diagnostic healthcare company offering pathology and medical testing services through a network of laboratories and collection centers across the Delhi/NCR region.
The company provides comprehensive diagnostic services including biochemistry, hematology, microbiology, virology, genetic testing, health checkups, corporate health packages, and blood bank services, emphasizing quality and timely results.
Established from a legacy pathology practice and NABL-accredited facilities, Dr Lalchandani Labs serves patients, hospitals, and healthcare providers with advanced equipment and multiple collection centers.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding working capital requirements of the Company | 1.27 |
| 2 | Adjustment of unsecured loans against the entitlement of Promoter | 1.11 |
| 3 | Repayment / Settlement of Certain Outstanding Borrowings | 0.65 |
| 4 | General corporate purpose | 1.08 |
[Dilip Davda] DLLL is engaged in providing diagnostic and related healthcare tests and services. The company posted inconsistency in its top and bottom lines for the reported periods. Surprisingly, it has not given any financial data for any period of FY26. The company has defaulted on employee benefits statutory payments. Though the RI is at par, it appears fully priced and its recent financial performance does not support the pricing. Doubled equity post RI indicates its servicing issue. Only well-informed/cash surplus/risk savvy investors may park moderate funds for medium term. Read detail review...
Dr Lalchandani Labs Rights Issue 2026 got subscribed by 0.78 times by the end of the bidding period with total bid quantity received by BSE of 33,72,000 shares. Check Day by Day Subscription Details (Live Status)
| Date | BSE Bid Quantity | Subscription Times |
|---|---|---|
Feb 27 2026 17:00:00 | 33,72,000 | 0.78x |
Dr Lalchandani Labs Ltd
M-20 Basement,
Greater Kailash-1,
South Delhi,
Delhi, 110048
The Dr Lalchandani Labs Rights Issue 2026 opens on Wed, Feb 4, 2026, and closes on Fri, Feb 27, 2026.
Dr Lalchandani Labs Rights Issue 2026 Schedule
| Last Date for credit of Rights Entitlements | Mon, Feb 2, 2026 |
| Last Date for renunciation of Rights Entitlements | Tue, Feb 24, 2026 |
| Issue Opening Date | Wed, Feb 4, 2026 |
| Issue Closing Date | Fri, Feb 27, 2026 |
| Date of Allotment (on or about) | Mon, Feb 23, 2026 |
| Date of Credit (on or about) | Tue, Feb 24, 2026 |
| Date of Listing (on or about) | Wed, Feb 25, 2026 |
You can apply for Dr Lalchandani Labs Rights Issue 2026 in two ways:
Steps to apply for Dr Lalchandani Labs Rights Issue 2026 using Net Banking (ASBA)
Steps to apply for Dr Lalchandani Labs Rights Issue 2026 using Registrar's website (R-WAP)
